European Journal of Dermatology
MENURituximab in pemphigus foliaceous with autoantibodies against both Desmoglein 1 and Desmoglein 3 Volume 21, numéro 3, May-June 2011
Illustrations
Department of Dermatology and Venereology, Curry Cabral Hospital, Lisbon, Portugal, Department of Pathology, Curry Cabral Hospital, Lisbon, Portugal
- DOI : 10.1684/ejd.2011.1288
- Page(s) : 415-6
- Année de parution : 2011
ejd.2011.1288 Auteur(s) : Rodrigo CARVALHO1 rodrigoaraujocarvalho@gmail.com, Paula MAIO1, Daniela CUNHA1, Isabel FREITAS1, Ana AFONSO2, Jorge CARDOSO1 1 Department of Dermatology and Venereology, Curry Cabral Hospital, Lisbon, Portugal 2 Department of Pathology, Curry Cabral Hospital, Lisbon, Portugal Reprints.: R. CARVALHO Pemphigus foliaceous (PF) is generally a benign autoimmune blistering disease, but in some patients lesions are severe with serious implications in life quality. We report a [...]